CD19 CAR–T cells of defined CD4

We performed an unbiased global proteomic profiling to elucidate the protein ex- pression profiles of resting (un-activated) and TCR- activated primary human CD4+

In this study, we compared the gene expression pro- files of CD4 þ T cells obtained from untreated MS patients and healthy controls and did not observe differential gene

To assess whether the observed higher PD1 and TIGIT expression on CD4 + T cells was restricted to a specific T cell differentiation stage, mucosal cells and PBMC were analyzed for

PGE 2 receptors EP 1–4 regulate unique and overlapping phosphosites in T cell subsets To map the PGE 2 -regulated phosphoproteome in T cells, we stimulated CD4 + T cells, CD8 +

Upon exposure to APC presenting the cognate antigen Id, Sh2d2a−/− CD4+ T cells expressing Id-specific transgenic T cell receptor (TCR), displayed impaired polarization of F-actin

Two activation protocols using anti-CD3/IL-2 or anti-CD3/CD28 antibodies were employed to study ALA-induced PpIX production and PDT effects on activated CD4 + CD25 + and CD8 + T

Boxplots on the sides show expression profiles for individual immune checkpoint genes in macrophages, CD4 + and CD8 + T cells isolated from healthy tissue (grey) and lung cancer

Even though ATRA 1 μM and valproic acid 500 and 1000 μM had no or only minor effects on T cell prolifer- ation and viability as well as the CD4:CD8 ratio, both drugs prolonged